InsiderTrades.com logo

TRP Insider Trading

Insider Ownership Percentage: 54.34%
Insider Buying (Last 12 Months): A$8,790.00
Insider Selling (Last 12 Months): A$0.00

Tissue Repair Insider Trading History Chart

This chart shows the insider buying and selling history at Tissue Repair by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tissue Repair Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 11/24/2021 10:07 AM ET

This chart shows the closing price history over time for TRP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Tissue Repair Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/26/2025Alistair McKeoughInsiderBuy30,000A$0.29A$8,790.00
6/2/2023Jack LowensteinInsiderBuy40,000A$0.28A$11,200.00
5/30/2023Jack LowensteinInsiderBuy35,000A$0.28A$9,800.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Tissue Repair (ASX:TRP)

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.
Read More on Tissue Repair

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

A$17.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Tissue Repair?

Tissue Repair's top insider investors include:
  1. Alistair McKeough (Insider)
Learn More about top insider investors at Tissue Repair.